Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 224

1.

Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma.

Che Y, Ye F, Xu R, Qing H, Wang X, Yin F, Cui M, Burstein D, Jiang B, Zhang DY.

Am J Pathol. 2012 May;180(5):1798-807. doi: 10.1016/j.ajpath.2012.01.016. Epub 2012 Mar 17.

PMID:
22429965
3.

Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.

Kim JK, Jung KH, Noh JH, Eun JW, Bae HJ, Xie HJ, Ahn YM, Ryu JC, Park WS, Lee JY, Nam SW.

Int J Oncol. 2009 Dec;35(6):1257-64.

PMID:
19885547
4.

Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.

Ito Y, Matsuura N, Sakon M, Miyoshi E, Noda K, Takeda T, Umeshita K, Nagano H, Nakamori S, Dono K, Tsujimoto M, Nakahara M, Nakao K, Taniguchi N, Monden M.

Hepatology. 1999 Jul;30(1):90-9.

PMID:
10385644
5.

KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis.

Sirach E, Bureau C, Péron JM, Pradayrol L, Vinel JP, Buscail L, Cordelier P.

Cell Death Differ. 2007 Jun;14(6):1202-10. Epub 2007 Mar 9.

6.

Clinicopathologic significance and function of S-phase kinase-associated protein 2 overexpression in hepatocellular carcinoma.

Zhang SH, Qian YM, Liu AW, Cai J, Zhao XL, Wei JJ, Zhu MH.

Hum Pathol. 2012 Jul;43(7):1084-93. doi: 10.1016/j.humpath.2011.08.019. Epub 2011 Dec 26.

PMID:
22204716
7.

NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.

Cheng J, Xie HY, Xu X, Wu J, Wei X, Su R, Zhang W, Lv Z, Zheng S, Zhou L.

Cancer Lett. 2011 Nov 1;310(1):35-45. doi: 10.1016/j.canlet.2011.06.001. Epub 2011 Jun 24.

PMID:
21763068
8.

Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.

Qi R, An H, Yu Y, Zhang M, Liu S, Xu H, Guo Z, Cheng T, Cao X.

Cancer Res. 2003 Dec 1;63(23):8323-9.

9.
10.
11.

Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis.

Masaki T, Shiratori Y, Rengifo W, Igarashi K, Yamagata M, Kurokohchi K, Uchida N, Miyauchi Y, Yoshiji H, Watanabe S, Omata M, Kuriyama S.

Hepatology. 2003 Mar;37(3):534-43.

PMID:
12601350
12.

Blockade of Rac1 activity induces G1 cell cycle arrest or apoptosis in breast cancer cells through downregulation of cyclin D1, survivin, and X-linked inhibitor of apoptosis protein.

Yoshida T, Zhang Y, Rivera Rosado LA, Chen J, Khan T, Moon SY, Zhang B.

Mol Cancer Ther. 2010 Jun;9(6):1657-68. doi: 10.1158/1535-7163.MCT-09-0906. Epub 2010 Jun 1.

14.

MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.

Li D, Liu X, Lin L, Hou J, Li N, Wang C, Wang P, Zhang Q, Zhang P, Zhou W, Wang Z, Ding G, Zhuang SM, Zheng L, Tao W, Cao X.

J Biol Chem. 2011 Oct 21;286(42):36677-85. doi: 10.1074/jbc.M111.270561. Epub 2011 Aug 30.

15.

PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.

Datta NS, Chen C, Berry JE, McCauley LK.

J Bone Miner Res. 2005 Jun;20(6):1051-64. Epub 2005 Jan 18.

16.

miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.

Li HP, Zeng XC, Zhang B, Long JT, Zhou B, Tan GS, Zeng WX, Chen W, Yang JY.

Carcinogenesis. 2013 Nov;34(11):2443-51. doi: 10.1093/carcin/bgt206. Epub 2013 Jun 5.

PMID:
23740840
17.

Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis.

Fujii T, Nomoto S, Koshikawa K, Yatabe Y, Teshigawara O, Mori T, Inoue S, Takeda S, Nakao A.

Hepatology. 2006 Jun;43(6):1267-75.

PMID:
16628605
18.
19.

[Correlations of expressions of macrophage migration inhibitor factor and cyclin D1 with tumor size and metastasis of hepatocellular carcinoma].

Xia JT, Li W, Liu YJ, Chen LZ, Wu ZF, Zhang LJ, Wang Q.

Zhonghua Gan Zang Bing Za Zhi. 2007 Dec;15(12):918-21. Chinese.

PMID:
18171527
20.

CADPE suppresses cyclin D1 expression in hepatocellular carcinoma by blocking IL-6-induced STAT3 activation.

Won C, Lee CS, Lee JK, Kim TJ, Lee KH, Yang YM, Kim YN, Ye SK, Chung MH.

Anticancer Res. 2010 Feb;30(2):481-8.

PMID:
20332458

Supplemental Content

Support Center